Visceral Leishmaniasis (VL) Clinical Presentation, Laboratory Findings, Treatment Options and Outcome

Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas. This study was a ret...

Full description

Saved in:
Bibliographic Details
Published inIranian journal of parasitology Vol. 19; no. 1; pp. 28 - 37
Main Authors Khodabandeh, Mahmoud, Moradian, Elham, Sarvari, Maedeh, Khiabani, Mahsa Soti
Format Journal Article
LanguageEnglish
Published Iran Tehran University of Medical Sciences 01.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas. This study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled. Twenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were. VL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration.
AbstractList Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas.   Methods: This study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled. Results: Twenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were. Conclusion: VL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration.
Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas. This study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled. Twenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were. VL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration.
Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas.   Methods: This study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled. Results: Twenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were. Conclusion: VL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration.
BackgroundBlack disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas.MethodsThis study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled.ResultsTwenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were.ConclusionVL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration.
Author Moradian, Elham
Sarvari, Maedeh
Khodabandeh, Mahmoud
Khiabani, Mahsa Soti
Author_xml – sequence: 1
  givenname: Mahmoud
  surname: Khodabandeh
  fullname: Khodabandeh, Mahmoud
  organization: Department of Pediatrics, Children's Medical Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 2
  givenname: Elham
  surname: Moradian
  fullname: Moradian, Elham
  organization: Children's Medical Center, Pediatrics Center of Excellence, Tehran, Iran
– sequence: 3
  givenname: Maedeh
  surname: Sarvari
  fullname: Sarvari, Maedeh
  organization: School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
– sequence: 4
  givenname: Mahsa Soti
  surname: Khiabani
  fullname: Khiabani, Mahsa Soti
  organization: Department of Pediatrics, Children's Medical Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38654944$$D View this record in MEDLINE/PubMed
BookMark eNpVkU9rGzEQxUVJadw0H6CXsscUsq60-rPyqQTTpAGDe0hDb2J2d-TI7EqutA7k21drJ6HRRaB58xu9eR_JiQ8eCfnM6JxpSatvbruD-SNbODZnki3oOzKrKNVlxfWfEzJjNZdlTSt6Ss5T2tJ8eKWVUh_IKddKioUQM4L3LrUYoS9W6NLDAN5Bcqm4uF99LZa9867NtV8RE_oRRhf8ZbGCJkQYQ3wqrp3vnN-ky-IuIoxDFhXr3SRLBfiuWO_HNgz4iby30Cc8f77PyO_rH3fLn-VqfXO7vFqVrWB6LFmHQqt6ISjKiitrW6RMZyPQtVI0ja5AQPbYCCaxYZ3SQoi6y95ZUwvW8TNye-R2AbZmF90A8ckEcObwEOLGQBxd26PRAixiPTG4kByBWYu26pqqsVbCxPp-ZO32zYBdm63lNb2Bvq1492A24dEwRjmXXGXCxTMhhr97TKMZpmX3PXgM-2Q4FUoyXimRpewobWNIKaJ9ncOoOcRtprjNIW5ziDv3fPn_g68dL-Hyf7leqrI
ContentType Journal Article
Copyright Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences.
Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences 2024
Copyright_xml – notice: Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences.
– notice: Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences 2024
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.18502/ijpa.v19i1.15190
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2008-238X
EndPage 37
ExternalDocumentID oai_doaj_org_article_84afee7d6843453ea1ffef2db2bff5ad
10_18502_ijpa_v19i1_15190
38654944
Genre Journal Article
GroupedDBID ---
2NT
2WC
3V.
53G
5GY
5VS
7X7
8C1
8FI
8FJ
8R4
8R5
ABDBF
ABUWG
ADBBV
ADRAZ
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CWDGH
DIK
EBD
ECGQY
EOJEC
ESX
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IPNFZ
KQ8
M48
M~E
NPM
OBODZ
OK1
PGMZT
PIMPY
PQQKQ
PROAC
Q2X
RIG
RNS
RPM
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c418t-1de4867940e5236ffce018173adc54bb82a4a200b415eb1d684447d1901b741d3
IEDL.DBID RPM
ISSN 1735-7020
IngestDate Tue Oct 22 15:16:01 EDT 2024
Tue Sep 17 21:28:21 EDT 2024
Sat Aug 17 05:18:52 EDT 2024
Fri Aug 23 03:06:05 EDT 2024
Sat Nov 02 11:54:08 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Treatment
Children
Diagnosis
Iran
Visceral leishmaniasis
Epidemiology
Language English
License Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c418t-1de4867940e5236ffce018173adc54bb82a4a200b415eb1d684447d1901b741d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11033536/
PMID 38654944
PQID 3046513264
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_84afee7d6843453ea1ffef2db2bff5ad
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11033536
proquest_miscellaneous_3046513264
crossref_primary_10_18502_ijpa_v19i1_15190
pubmed_primary_38654944
PublicationCentury 2000
PublicationDate 2024-01-01
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Iran
PublicationPlace_xml – name: Iran
PublicationTitle Iranian journal of parasitology
PublicationTitleAlternate Iran J Parasitol
PublicationYear 2024
Publisher Tehran University of Medical Sciences
Publisher_xml – name: Tehran University of Medical Sciences
SSID ssj0000328666
Score 2.3303537
Snippet Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various species. The risk of morbidity and mortality increases with...
Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and...
BackgroundBlack disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 28
SubjectTerms Children
Diagnosis
Epidemiology
Iran
Original
Treatment
Visceral leishmaniasis
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUQh4oLKhToQqlciQNUBBLHzjrHFnWF0PJxAMTN8qc2CLKI7Fbqv--Mk4VdVKkXrnGiWG9GM2_s8TMhe5l1orRcJ6hNl3DNbFJabHaAVC-dcYKleDj5_KI4veFnd-Ju7qov7Alr5YFb4I4l18H7viskz7nIvc5C8IE5w0wIQrsYfdNyrpiKMThnsogblVkfNRmBFHVbmlKk7Li6f9JHv7Oyyo4g42E8nktKUbv_X4Tzbd_kXCIafCSrHYOkP9qZr5ElX6-TD-fdHvkn4m-rxuJKEx36qhmhvoVuqobu3w4PaCcD-kCvXo8d1Yd02LrC-PkPHVTxnEtzSK9nPej0su18obp29HI6ASf1G-Rm8Ov65DTpLlNILM_kJMmcj-J6PPVQexYhWI9aXf1cOyu4MZJpsFSaGsjoEL8Rb877DvmCAdbh8k2yXI9r_5nQAoKkzYSTaWk4GAc-Lo0BqiFd6lhgPfJ9hqZ6ajUzFNYaCL1C6FWEXkXoe-Qn4v3yIspdxwfgBKpzAvU_J-iRbzNrqUcE-QE7hcfTRuHGr4CKu-A9stVa7-VXeN0pLzmMyAW7LsxlcaSuRlGCG0hTnou82H6P2e-QFQZUqV3Y-UKWJ89TvwtUZ2K-Rq_-C6uE_ok
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LTxsxELYQlbhVfdA2fcmVOLSITXe99sZ7qKq2IkJVgB4I4mb5WRaFDc0mFfx7Zrwb2qAckPa0L1vjsecbz_gbQnYy60RpuU6Qmy7hmtmktJjsAKZeOuMES_Fw8uFRcTDmP8_E2QZZlrfqBNisde2wntR4Nulf_7n5ChP-C054KVL2ubq40v2_WVllfTBgJXjwjxgHRx0z-Tq0HxfmnMkiRi-zARI1AlLq4pxr_7JiqSKh_zoUej-Z8j_rNHxCHnewkn5r9eAp2fD1M7J12AXOnxN_WjUWt5_oyFfNOZJe6KZq6MfT0SfacYNO6K9_Z5HqPTpq9WM6u6HDKh5-afboyTIxnR636TBU144eL-aguX6bjIf7Jz8Okq7CQmJ5JudJ5nxk3OOpB4e0CMF6JPAa5NpZwY2RTMPwpakBMw-Luisk53zgEEQYgCIuf0E262ntXxFawMppM-FkWhoevIePS2MAf0iXOhZYj-wupamuWiINhQ4Iil6h6FUUvYqi75HvKO-7F5EDO96Yzn6rbkopyTW0M8BO5VzkXmch-MCcYSYEoV2PfFiOlrpEIU8wfXi6aBRGgwW44QXvkZft6N01hTVQecnhiVwZ15W-rD6pq_PIyw1IKs9FXrx-QMNvcIMg7uTA9ZZszmcL_w7gzdy8j0p7C5w8-ag
  priority: 102
  providerName: Scholars Portal
Title Visceral Leishmaniasis (VL) Clinical Presentation, Laboratory Findings, Treatment Options and Outcome
URI https://www.ncbi.nlm.nih.gov/pubmed/38654944
https://search.proquest.com/docview/3046513264
https://pubmed.ncbi.nlm.nih.gov/PMC11033536
https://doaj.org/article/84afee7d6843453ea1ffef2db2bff5ad
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2ISFeEN90g8pIPABa2tixE-eRlZUKtVuFttG3yF9hQW1aNS0S_z1nJxkt4omXRIpj2bo73Yfv7meE3hJteKqZDBw2XcAk1UGqXbEDmHphlOE0dM3Jk4t4dM2-zPjsAMVtL4wv2teq6JXzRa8sbn1t5Wqh-22dWH86GYDJiiIexf1DdAgSuhOje_0bURH7JCVJHB4jOERNOlPwkPaLHyvZ-0nSgvTA2jldvGOQPG7_v5zNv2smd4zQ8BF62HiP-GO9y8fowJZP0P1Jkx9_iuxNUWl3yoTHtqhuHbaFrIoKv7sZv8cNBOgcT_-0HJWneFyLwXL9Cw8L3-NSneKrtv4cX9ZVL1iWBl9uNyCg9hm6Hp5fDUZBc5FCoBkRm4AY64H1WGgh7ozzXFuH05VE0mjOlBJUApfCUIE1B91tYsEYS4zzFRR4HCZ6jo7KZWlfIhyDgtSEGxGmiuXWwuRUKXAzhAkNzWkHfWipma1qvIzMxRmO9JkjfeZJn3nSd9CZo_fdjw7q2n9Yrr9nDcMzwSSsk7hNRYxHVpI8tzk1iqo859J00JuWW9nCEXnuqoSX2ypzSV8O0XbMOuhFzb27pdxVpyxlMCL2-Lq3l_0RkEYPv91K3_H_Tz1BDyg4R_VRzit0tFlv7WtwbjaqCxI9S-ApBqSL7p2dX0y_wnvw7dPnUdcfGMBzwkTXy_xvSNAB7A
link.rule.ids 230,315,730,783,787,867,888,2109,2228,24330,27936,27937,31732,33279,33757,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaWRQIuiDflaSQOgDZt4tipc4QVVYF2dw_d1d4sv8IGtWnVtEj8e2acZGkRJ65xLFszE883npkvhLxNrBO55TpCbrqIa2aj3GKxA7h66YwTLMbm5OlJNj7nXy_F5QHJul6YULRvTdmv5ot-VV6F2srVwg66OrHB2fQYXFaaijQb3CA34YON-U6UHk7glMkspCmTITIyAiRqE5pSxGxQ_ljp_s8kL5M--Ds8jXdcUmDu_xfc_LtqcscNje6Ruy1-pB-bfd4nB756QG5N2wz5Q-IvytriPROd-LK-QnYLXZc1fXcxeU9bEtA5PfvTdFQd0UljCMv1LzoqQ5dLfURnXQU6PW3qXqiuHD3dbsBE_SNyPvo8Ox5H7a8UIssTuYkS5wO1Ho89RJ5ZUViPTF3DVDsruDGSadBTHBvw53B6u0xyzocO0YIBzOHSx-SwWlb-KaEZSNwmwsk4N7zwHibnxgDQkC52rGA98qGTplo1jBkKIw0UvULRqyB6FUTfI59Q3tcvItl1eLBcf1etypXkGtYZ4qZSLlKvk6LwBXOGmaIQ2vXIm05baoFCnmOd8HJbK0z7Coi3M94jTxrtXS-FPzvlOYcRuafXvb3sj4A9BgLuzv6e_f_U1-T2eDadqMmXk2_PyR0GUKm52HlBDjfrrX8JUGdjXgW7_g3j9_6G
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSBMvE-PajYuReAC0NIljp87jGFQD2q0P27Q3y1eWqU2rpkXi33PsJKNFPPEax7J1zonPZ5_PXxB6l2rDCk1l5LXpIiqJjgrtyQ6Q6rlRhpHEX04en-Wnl_TbNbtuWZV1S6ustCr71XTWr8qbwK1czHTc8cTiyfgEUlaWsSyPF8bF99ED-GiTfGOnHlbhjPA8lCrTgVdlBFjUFjU5S0hc3i5k_2dalGkfcp5fkTfSUlDv_xfk_Js5uZGKho_QXosh8XEz1310z1aP0e64rZI_QfaqrLU_a8IjW9Y3XuFC1mWN31-NPuBWCHSKJ38uHlVHeNQEw3z5Cw_LcNOlPsIXHQsdnzfcFywrg8_XKwhT-xRdDr9cnJxG7e8UIk1TvopSY4O8Hk0s7D5z57T1al2DTBrNqFKcSPBVkijI6bCCm5xTSgfGIwYFuMNkz9BONa_sC4RzsLhOmeFJoaizFjoXSgHY4CYxxJEe-thZUywa1Qzhdxve9MKbXgTTi2D6Hvrk7X33ohe8Dg_myx-idbvgVMI4Az-pjLLMytQ564hRRDnHpOmht523xMwbeeq5wvN1LXzpl8GeO6c99Lzx3t1Q_oentKDQwrf8ujWX7RaIySDC3cXgwf93fYN2J5-HYvT17PshekgALTVnOy_Rzmq5tq8A7azU6xDWvwGFi_-Z
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Visceral+Leishmaniasis+%28VL%29+Clinical+Presentation%2C+Laboratory+Findings%2C+Treatment+Options+and+Outcome&rft.jtitle=Iranian+journal+of+parasitology&rft.au=Khodabandeh%2C+Mahmoud&rft.au=Moradian%2C+Elham&rft.au=Sarvari%2C+Maedeh&rft.au=Khiabani%2C+Mahsa+Soti&rft.date=2024-01-01&rft.issn=1735-7020&rft.volume=19&rft.issue=1&rft.spage=28&rft.epage=37&rft_id=info:doi/10.18502%2Fijpa.v19i1.15190&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1735-7020&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1735-7020&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1735-7020&client=summon